GSA Capital Partners’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$332K Buy
+163,260
New +$332K 0.02% 1195
2024
Q2
Sell
-79,979
Closed -$1.11M 1820
2024
Q1
$1.11M Sell
79,979
-236,398
-75% -$3.28M 0.09% 372
2023
Q4
$1.94M Buy
316,377
+291,631
+1,178% +$1.78M 0.16% 129
2023
Q3
$116K Buy
+24,746
New +$116K 0.01% 1371
2023
Q2
Sell
-8,356
Closed -$82K 1711
2023
Q1
$82K Sell
8,356
-4,984
-37% -$48.9K 0.01% 1377
2022
Q4
$250K Buy
+13,340
New +$250K 0.03% 1050
2022
Q3
Sell
-3,230
Closed -$67K 1689
2022
Q2
$67K Sell
3,230
-4,857
-60% -$101K 0.01% 1263
2022
Q1
$348K Buy
8,087
+3,507
+77% +$151K 0.05% 792
2021
Q4
$274K Buy
4,580
+1,755
+62% +$105K 0.03% 1000
2021
Q3
$243K Buy
2,825
+849
+43% +$73K 0.02% 1137
2021
Q2
$220K Sell
1,976
-71
-3% -$7.91K 0.02% 1135
2021
Q1
$228K Buy
2,047
+473
+30% +$52.7K 0.04% 817
2020
Q4
$167K Buy
+1,574
New +$167K 0.03% 1030
2020
Q2
Sell
-2,288
Closed -$204K 850
2020
Q1
$204K Buy
+2,288
New +$204K 0.05% 748
2017
Q4
Sell
-9,608
Closed -$731K 1672
2017
Q3
$731K Sell
9,608
-1,392
-13% -$106K 0.05% 713
2017
Q2
$1.04M Buy
+11,000
New +$1.04M 0.07% 521
2016
Q4
Sell
-7,867
Closed -$880K 1852
2016
Q3
$880K Buy
7,867
+2,100
+36% +$235K 0.05% 688
2016
Q2
$639K Buy
5,767
+3,650
+172% +$404K 0.04% 937
2016
Q1
$221K Sell
2,117
-866
-29% -$90.4K 0.01% 1450
2015
Q4
$241K Buy
+2,983
New +$241K 0.01% 1572
2015
Q3
Sell
-7,183
Closed -$703K 1875
2015
Q2
$703K Buy
7,183
+4,241
+144% +$415K 0.03% 1143
2015
Q1
$288K Buy
+2,942
New +$288K 0.01% 1732
2014
Q4
Sell
-1,283
Closed -$152K 1798
2014
Q3
$152K Buy
+1,283
New +$152K 0.01% 1574